In the modern age of pharmaceuticals, the role of a hero often shifts from the battlefield to the laboratory. ‘Dying to Survive,’ a documentary that delves into the struggles and triumphs of Chinese pharmaceutical innovators, captures this shift beautifully. This review aims to explore the narrative, characters, and impact of the film, offering a glimpse into the world of modern pharmaceutical heroes.
Introduction to ‘Dying to Survive’
‘Dying to Survive’ is a 2017 Chinese documentary directed by Chen Lili. The film follows the real-life experiences of Chinese pharmaceutical entrepreneurs and their relentless pursuit of affordable and effective treatments for life-threatening diseases. The documentary showcases the challenges they face, including patent disputes, corruption, and the relentless pursuit of medical advancements.
The Narrative Arc
The documentary follows a narrative arc that begins with the struggles of patients who cannot afford life-saving medications. It then transitions to the journey of Chinese pharmaceutical innovators as they develop generic drugs to make these medications accessible to a broader population. The narrative is interspersed with interviews, personal anecdotes, and dramatic scenes that highlight the emotional and financial toll of the pursuit.
Opening: The Plight of Patients
The film opens with heart-wrenching interviews of patients suffering from diseases like HIV/AIDS, cancer, and hepatitis C. These individuals share their experiences of going through extensive medical treatments, only to face the harsh reality of high medication costs. This sets the stage for the documentary’s central theme: the unaffordable cost of life-saving drugs.
The Innovators’ Journey
The documentary then shifts its focus to the pharmaceutical entrepreneurs who are determined to change this reality. The film follows the story of Chen Zhi, a young entrepreneur who decides to take on the challenge of producing a generic version of the antiretroviral drug Sovaldi, which costs approximately $84,000 for a 12-week treatment in the United States.
The Challenges
The film highlights the numerous challenges faced by these innovators, including:
- Patent Disputes: The struggle to produce generic versions of patented drugs often leads to legal battles with pharmaceutical giants.
- Corruption: The pharmaceutical industry is riddled with corruption, which can hinder the development and distribution of generic drugs.
- Financial Strain: The innovators must often invest their own money and take significant financial risks to bring affordable medications to the market.
The Triumph
Despite the challenges, the documentary showcases the triumph of these innovators. Chen Zhi and his team succeed in producing a generic version of Sovaldi, which is priced at just $800 for a 12-week treatment. This breakthrough brings hope to countless patients who can now afford life-saving medication.
Characters
The documentary features several compelling characters, each playing a crucial role in the narrative:
- Chen Zhi: The young entrepreneur who takes on the challenge of producing a generic version of Sovaldi.
- Patients: The individuals who suffer from life-threatening diseases and are reliant on affordable medications.
- Regulators: The officials who work to ensure the safety and efficacy of generic drugs.
- Pharmaceutical Company Executives: The individuals responsible for the high cost of patented drugs.
Impact and Legacy
‘Dying to Survive’ has had a significant impact on the global conversation about the cost of pharmaceuticals. The film has sparked discussions about the role of generic drugs in making life-saving medications accessible to those in need. Additionally, it has brought attention to the challenges faced by pharmaceutical innovators in developing affordable treatments.
Conclusion
‘Dying to Survive’ is a powerful documentary that showcases the dedication and perseverance of modern pharmaceutical heroes. The film provides a captivating narrative of the struggles and triumphs of Chinese pharmaceutical innovators, offering a glimpse into the world of affordable medication. It is a must-watch for anyone interested in the intersection of healthcare, innovation, and social justice.